Company intelligence / Profile preview

Promea Therapeutics

Hyderabad, Telangana, Indiapromea.in ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Promea Therapeutics develops and manufactures a range of life science products including in vitro diagnostic medical devices (clinical chemistry, immunodiagnostics, molecular diagnostics), large & small volume parenterals, and biologic products. Their offerings are available commercially with a focus on quality manufacturing for global healthcare markets. No clinical trial results are reported as their main business is manufacturing rather than drug development.

Therapeutic areas: OtherImmunology
Modalities: BiologicDiagnostic deviceInfusion therapy (parenteral solutions)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Promea Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promea Therapeutics.

Explore the full profile